The market dynamics for Acquired Blepharoptosis are expected to witness steady growth driven by the rising burden of age-related eyelid disorders, increasing demand for functional and cosmetic correction, and growing
The market dynamics for Acute Respiratory Distress Syndrome (ARDS) are witnessing steady growth driven by the rising incidence of pneumonia, sepsis, trauma, and severe respiratory infections, alongside the high unmet
The market dynamics for ESR1-mutated Metastatic Breast Cancer are witnessing steady growth driven by the increasing prevalence of endocrine therapy resistance, rising adoption of biomarker testing, and growing demand for
The Key Congestive Heart Failure Companies in the market include – Novartis, Boehringer Ingelheim, Eli Lilly and Company, Bayer, Cytokinetics, BioCardia, Novo Nordisk, and others. (Albany, US), October 29, 2026
The Key Familial Chylomicronemia Syndrome Companies in the market include – Ionis Pharmaceuticals, Swedish Orphan Biovitrum, Arrowhead Pharmaceuticals, and others. (Albany, US), October 29, 2026 – DelveInsight’s ‘Familial Chylomicronemia Syndrome
The Key Pertussis Companies in the market include – Sanofi, GSK, Biken, KM Biologics, ILiAD Biotechnologies, Mitsubishi Tanabe Pharma Corporation, Cansino Bio, and others. (Albany, US), October 29, 2026 –
The HDAC Inhibitors clinical trial analysis report delivers important insights into ongoing research on 55+ pipeline drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October 29, 2026
The Key Triple Negative Breast Cancer Companies in the market include – Merck, Gilead Sciences, Pfizer, AstraZeneca, Hoffmann-La Roche, Daiichi Sankyo, Galera Therapeutics, and others. (Albany, US), October 29, 2026
The Key Malignant Pleural Effusion Companies in the market include – Gongwing Biopharm, Wuhan YZY Biopharma, RS Oncology, Genelux Corporation, and others. (Albany, US), October 29, 2026 – DelveInsight’s “Malignant
The Hemophilia A clinical trial analysis report delivers important insights into ongoing research on 40+ pipeline drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October 29, 2026-
The Follicular Lymphoma clinical trial analysis report delivers important insights into ongoing research on 50+ pipeline drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October 29, 2026,
The Esophageal Squamous Cell Carcinoma clinical trial analysis report delivers important insights into ongoing research on 50+ pipeline drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October
Hyderabad – Oct 29th, 2026 – Laboratory Freezers Market Overview According to Mordor Intelligence, the Laboratory Freezers Market is projected to register a CAGR of 4.50% during the forecast period
India Mutual Fund Market Size and Share | Mordor Intelligence Mordor Intelligence has published a new report on the India Mutual Fund Market offering a comprehensive analysis of trends, growth
LNG Vehicle Market Mordor Intelligence has published a new report on the LNG Vehicle Market offering a comprehensive analysis of trends, growth drivers, and future projections. Hyderabad – Oct 29th,
Hyderabad – Oct 29th, 2026 – Rabies Diagnostics Market Overview According to Mordor Intelligence, the Rabies Diagnostics Market was valued at USD 2.11 billion in 2025 and is projected to
Window Films Market According to Mordor Intelligence, Window Films Market Size, Share & Trends Forecast 2026-2031,” offers an in-depth analysis of the regional dynamics shaping this rapidly evolving industry. Hyderabad
Spain Solar Energy Market The latest research by Mordor Intelligence covers the “Spain Solar Energy Market” delivering insights into market dynamics, drivers of growth, and long-term forecasts. Hyderabad – Oct
Brewing Enzymes Market Size & Trends | Mordor Intelligence Mordor Intelligence has published a new report on the brewing enzyme market, offering a comprehensive analysis of market trends, growth drivers,
NEW YORK, NY – October 29, 2026 – Global contemporary womenswear manufacturer Zeagoo has unveiled its Fall/Winter 2026 color-focused capsule selection, featuring rich burgundy, deep chocolate brown, and warm cream palettes.
